People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...
The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...